Drug Delivery Systems Using Nanoparticle Carriers

Summary

Drug delivery systems based on nanoparticle carriers have transformed therapeutic strategies by enhancing the precision, efficacy and safety of a wide range of pharmaceuticals. At the core of these systems are engineered particles—ranging from lipid‐based vesicles to polymeric nanospheres—designed to encapsulate active compounds, protect them from degradation, and release them at the intended site of action. By tuning size, surface chemistry and mechanical properties, researchers can influence circulation time, cellular uptake and tissue distribution, thereby minimising off‐target effects and improving patient outcomes. Liposomal formulations, polymeric nanoparticles and solid lipid constructs each present unique advantages: liposomes offer biocompatibility and facile drug loading, polymeric systems enable controlled release kinetics, and hybrid materials combine multiple functionalities. Targeting moieties such as antibodies, peptides or small molecules further refine specificity, while stimuli‐responsive designs (pH, temperature or enzymatic triggers) provide on‐demand release. Together, these innovations address global challenges in oncology, infectious disease and chronic conditions, laying the groundwork for next‐generation personalised therapies.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Research from all publishers

Recent reviews have emphasised the integration of artificial intelligence (AI) with nanoparticle development to accelerate design and optimise performance. Innovative workflows now employ machine learning to predict stability, biodistribution and release profiles, reducing experimental burden and guiding rational formulation. This AI-driven paradigm has led to bespoke nanocarriers tailored for complex cargos such as nucleic acids and combination therapies, marking a shift towards data‐informed nanomedicine.

Advances in high‐resolution imaging techniques have yielded unprecedented insight into carrier morphology and drug localisation at the single‐particle level. Quantitative cryogenic transmission electron microscopy has been used to characterise clinically established formulations, revealing heterogeneity in shape and internal structure that correlates with release behaviour. Such detailed structural maps inform the fine‐tuning of lipid composition and drug‐to‐carrier ratios, thereby enhancing batch consistency and therapeutic index.

Seminal work on clinically used liposomal vehicles continues to underscore their translational value. Updated reviews of liposomal platforms highlight steady progress in stealth technologies and multivesicular systems, which extend circulation half‐life and enable sustained release. These formulations have been successfully applied to deliver anticancer agents, antifungals and biologics, demonstrating improved efficacy in tumour models and enabling the clinical approval of novel nano‐drugs.

Drug Delivery Systems Using Nanoparticle Carriers publication trend

The graph below shows the total number of articles in drug delivery systems using nanoparticle carriers across all publications each year (not limited to Nature Index journals).

Technical terms

Liposome: A spherical vesicle composed of one or more phospholipid bilayers, used to encapsulate aqueous or lipophilic drugs.

Polymeric nanoparticle: A solid colloidal particle formed from biodegradable polymers, designed for controlled drug release.

PEGylation: The attachment of polyethylene glycol chains to a nanoparticle surface to reduce immunogenicity and extend circulation time.

Stimuli‐responsive carrier: A nanocarrier engineered to release its payload in response to specific environmental triggers such as pH or enzymatic activity.

Biodistribution: The distribution of a drug or carrier throughout the body’s tissues and organs following administration.

References

  1. Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics (2017).
  2. Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence. Pharmaceutics (2022).
  3. Quantitative Cryo-TEM Reveals New Structural Details of Doxil-Like PEGylated Liposomal Doxorubicin Formulation. Pharmaceutics (2021).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.